Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US firm Jaguar Health has achieved a key regulatory milestone as it works towards US FDA approval of Canalevia.
The European Medicines Agency (EMA) has introduced a system of electronic certificates for newly approved human and veterinary medicines.
The FDA's Center for Veterinary Medicine (CVM) has issued a warning related to the use of chloroquine phosphate – a treatment for aquarium fish.
California-based Ark Animal Health hopes to begin pivotal studies for its resiniferatoxin (RTX) canine pain management therapeutic later this year.
Animal Medicines Australia (AMA) has assured industry it is working to maintain an uninterrupted supply of veterinary medicines and animal health products.
The European Medicines Agency (EMA) has revealed there have been 22 minor use/minor species (MUMS) authorizations for veterinary medicines over the last decade.
Vetoquinol is close to getting European centralized approval for a generic food animal antibacterial.
The US FDA has approved Dechra Pharmacueticals' Marboquin tablets for companion animals.
France's Vetoquinol has donated over 6,000 masks to its nearby healthcare facilities.
Kindred Biosciences has secured positive results from a pilot field efficacy study of its treatment for canine atopic dermatitis.
The European Commission has listed veterinary medicines as 'essential goods' in its guidelines for the transport of goods.
Carus Animal Health's latest R&D deal aims to harness bacteriophages as antibiotic alternatives to combat companion animal diseases.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.